Neurocrine Biosciences, Inc. (NASDAQ:NBIX) – Analysts at Jefferies Group lowered their FY2020 EPS estimates for Neurocrine Biosciences in a note issued to investors on Tuesday. Jefferies Group analyst B. Amin now anticipates that the company will earn $2.55 per share for the year, down from their prior estimate of $2.80. Jefferies Group currently has a […]
